Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v3-EN
Language French English
Date Updated 2024-09-10 2024-04-03
Drug Identification Number 02347091 02347091
Brand name SANDOZ VALACYCLOVIR SANDOZ VALACYCLOVIR
Common or Proper name VALACYCLOVIR VALACYCLOVIR
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients VALACYCLOVIR VALACYCLOVIR
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90FCT BO 90FCT BO
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2024-04-02 2024-04-02
Estimated end date 2025-01-17 2024-07-05
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments